Molecular cloning and expression analysis of pig lymphocyte activation gene-3 (LAG-3; CD223)

被引:11
|
作者
Kim, Seon-Soo [1 ,2 ]
Kim, Sang-Hoon [1 ]
Kang, Hyung-Sik [3 ]
Chung, Hee Yong [2 ]
Choi, Inho [4 ]
Cheon, Yong-Pil [5 ]
Lee, Ki Ho [6 ]
Lee, Dong-Mok [4 ]
Park, Jongsun [7 ]
Lee, Sang Yeol [8 ]
Chun, Taehoon [1 ]
机构
[1] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea
[2] Hanyang Univ, Dept Microbiol & Immunol, Sch Med, Seoul 133791, South Korea
[3] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea
[4] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea
[5] Sungshin Womens Univ, Coll Nat Sci, Dept Biol, Inst Basic Sci, Seoul 136742, South Korea
[6] Eulji Univ, Sch Med, Dept Biochem & Mol Biol, Taejon 301832, South Korea
[7] Chungnam Natl Univ, Cell Signaling Lab, Canc Res Inst, Res Inst Med Sci,Coll Med, Taejon 305764, South Korea
[8] Kyungwon Univ, Coll Nat Sci, Dept Life Sci, Seoul 461701, South Korea
关键词
Co-receptor; Immune homeostasis; Lymphocyte activation gene-3; Pig; T cell activation; T-CELLS; PROTEIN; PROLIFERATION; ANTIGENS; DNA;
D O I
10.1016/j.vetimm.2009.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphocyte activation gene-3 (LAG-3; CD223) is a co-receptor that may function as a down-modulator of T cell activity via an interaction with MHC class II molecules. In this study, we cloned and sequenced the complete cDNA sequence of pig Lag3. Pig Lag3 cDNA contains an open reading frame (1524 bp) encoding 507 amino acids. The putative amino acid identity of pig LAG-3 with those of the human, rat, and mouse is 78%, 66%, and 67%, respectively. Pig Lag3 mRNA transcript was mainly expressed in lymphoid tissues, and was inducible upon stimulation of phytohemagglutinin (PHA). Next, we developed mouse antiserum against the extracellular domain (D1 and D2 domains) of pig LAG-3. Pig LAG-3 is detected as an approximately 67 kDa of a single species by Western blot analysis. Moreover, flow cytometry analysis confirmed that LAG-3 on pig T cells (CD3(+) cells) is inducible upon PHA stimulation. These results indicated that the structure and expression pattern of pig LAG-3 are conserved among mammalian species. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 50 条
  • [41] Phase 1 study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, plus cemiplimab in advanced melanoma
    Hamid, Omid
    Weise, Amy
    Kim, Tae Min
    McKean, Meredith
    Lakhani, Nehal J.
    Kaczmar, John
    Papadopoulos, Kyriakos P.
    Chen, Shuquan
    Mani, Jayakumar
    Jankovic, Vladimir
    Kroog, Glenn
    Sims, Tasha
    Lowy, Israel
    Gullo, Giuseppe
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 127 - 127
  • [42] Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced NSCLC
    Cho, Byoung Chul
    Dy, Grace K.
    Kim, Tae Min
    Sarker, Debashis
    Hamid, Omid
    Williamson, Stephen K.
    Kim, Sang-We
    Husain, Hatim
    Chen, Shuquan
    Mani, Jayakumar
    Jankovic, Vladimir
    Paccaly, Anne
    Masinde, Sheila
    Lowy, Israel
    Brennan, Laura
    Gullo, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S25 - S25
  • [43] Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma
    Hamid, Omid
    Lewis, Karl D.
    Weise, Amy
    McKean, Meredith
    Papadopoulos, Kyriakos P.
    Crown, John
    Kim, Tae Min
    Lee, Dae Ho
    Thomas, Sajeve S.
    Mehnert, Janice
    Kaczmar, John
    Lakhani, Nehal J.
    Kim, Kevin B.
    Middleton, Mark R.
    Rabinowits, Guilherme
    Spira, Alexander I.
    Yushak, Melinda
    Mehmi, Inderjit
    Fang, Fang
    Chen, Shuquan
    Mani, Jayakumar
    Jankovic, Vladimir
    Wang, Fang
    Fiaschi, Nathalie
    Brennan, Laura
    Paccaly, Anne
    Masinde, Sheila
    Salvati, Mark
    Fury, Matthew G.
    Kroog, Glenn
    Lowy, Israel
    Gullo, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (24)
  • [44] Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine
    Ausiello, CM
    Palazzo, R
    Spensieri, F
    Urbani, F
    Massari, M
    Triebel, F
    Benagiano, M
    D'Elios, MM
    Del Prete, G
    Cassone, A
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (01) : 97 - 104
  • [45] Prognostic significance of lymphocyte activation gene-3 (LAG3 gene) in uveal melanoma patients
    Singh, L.
    Singh, M. K.
    Kumar, N.
    Jha, J.
    Lomi, N.
    Sen, S.
    Kashyap, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1463 - S1464
  • [46] Phase 1 study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis
    Hamid, Omid
    Weise, Amy
    Lewis, Karl D.
    Kim, Tae Min
    McKean, Meredith
    Lakhani, Nehal J.
    Kaczmar, John
    Papadopoulos, Kyriakos P.
    Chen, Shuquan
    Mani, Jayakumar
    Gullo, Giuseppe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB207 - AB207
  • [47] Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)
    Hamid, O.
    Weise, A.
    Kim, T. M.
    Mckean, M.
    Lakhani, N.
    Crown, J.
    Kaczmar, J.
    Papadopoulos, K.
    Chen, S.
    Mani, J.
    Jankovic, V.
    Kroog, G.
    Sims, T.
    Lowy, I.
    Gullo, G.
    ANNALS OF ONCOLOGY, 2022, 33 : S1598 - S1598
  • [48] Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)
    Hamid, O.
    Weise, A.
    Kim, T. M.
    Mckean, M. A.
    Lakhani, N. J.
    Kaczmar, J.
    Papadopoulos, K. P.
    Chen, S.
    Mani, J.
    Jankovic, V.
    Kroog, G.
    Sims, T.
    Lowy, I.
    Gullo, G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S905 - S905
  • [49] LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
    Kluemper, Niklas
    Ralser, Damian J.
    Bawden, Emma Grace
    Landsberg, Jenny
    Zarbl, Romina
    Kristiansen, Glen
    Toma, Marieta
    Ritter, Manuel
    Hoelzel, Michael
    Ellinger, Joerg
    Dietrich, Dimo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [50] CD4/MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INTERACTION ANALYZED WITH CD4 AND LYMPHOCYTE-ACTIVATION GENE-3 (LAG-3)-IG FUSION PROTEINS
    HUARD, B
    PRIGENT, P
    TOURNIER, M
    BRUNIQUEL, D
    TRIEBEL, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2718 - 2721